Psycon Psychedelic Convention

Denver, Colorado

DENVER, COLORADO

Denver Convention Center
October 10-12, 2024
In 2019, Denver became the first city in the United States to decriminalize psilocybin, kicking off a wave of psychedelic policy reform throughout the nation. Now in 2024, natural medicines are decriminalized statewide, and Colorado officials are preparing to roll out a regulated program for their facilitated use. PsyCon is the premier trade show and expo for Colorado’s emerging psychedelic industry. Featuring the top names in psychedelic science presenting the latest cutting-edge research, PsyCon offers entrepreneurs and consumers alike the chance to learn, network, and build the foundation for what could soon be one of the biggest psychedelic markets in the nation.
TICKET SALES END IN:
Days
Hours
Minutes
Seconds

Get Tickets

NO REFUNDS all sales are final
Ticket Type
Description
Early Bird Ticket Price (thru 8/26)
On Site Price
Friday 1 Day Conference Ticket
Access to the exhibit hall and all seminar rooms on Friday October 11 only.
$99
$139
Saturday 1 Day Conference Ticket
Access to the exhibit hall and all seminar rooms on Saturday October 12 only.
$99
$139
2 Day Conference Ticket
Access to the exhibit hall and all seminar rooms on Friday + Saturday + After Party.
$199
$299
3 Day Conference Ticket (includes Pre-Show Course)
Access to the exhibit hall and all seminar rooms on Friday + Saturday + After Party. Access to the Thursday Pre-Show Crash Course.
$399
$499

Hear from experts - speaker list Denver 2024

6665f13e361c8
Dan HS Color 2023

Rocco Iannapollo & Dan Huson

Testing and labeling standards for Psychedelic Mushrooms

Presentation Abstract:
Immerse yourself in a riveting fireside chat at the forefront of natural medicine! Our dynamic panel of industry leaders is set to delve into the latest topics, covering everything from testing and harm reduction to cutting-edge studies to advocacy and decriminalization work. Get ready for a deep dive

Speaker Bio: Rocco Iannapollo
Rocco came to the natural medicine industry in 2015, bringing decades of experience from Corporate America. He is Chief Brand Officer @ 710Sci, a founding member of the CannaConsortium, & Chairman of the board @ Psychedelics Standards Organization. He values diversity, inclusion, & sustainability.

Speaker Bio: Dan Huson
Dan Huson – Owner of Rose City Laboratories, currently the only fully licensed and accredited Lab to test Psilocybin. Dan is a seasoned and respected industry thought leader. His career has been rooted in improving ownership, integrity, and accountability. You won’t meet a more interesting and intuitive leader with a genuine trustworthiness his team admires. Previously, Dan worked at Boeing for (23 years) as well as a pioneer in opening one of the first medicinal cannabis dispensaries in Oregon. His entrepreneurial mind (which does not have an off switch) eventually pivoted towards laboratory testing, analytics, and accountability toward home health and wellness. This has led to the expansion into environmental test services and most recently, Psilocybin Testing including R & D. He has successfully owned and operated Rose City Labs in PDX since 2012, and now embraces a brand-new lab which opened in 2023 in Bend, OR.

668552a10c680

Amber Kerby & Stephan Kerby

Building a Bridge: Collaborative Approaches in Psychedelic Therapy Talk about the potential for collaboration between legal therapists and underground practitioners.

Presentation Abstract:
This is an exploration into the innovative and transformative potential of collaborative approaches in psychedelic therapy. In this unique presentation, a legal psychedelic-assisted therapist and an experienced underground practitioner come together to share their insights, challenges, and successes

Speaker Bio:
Amber Kerby is a licensed psychedelic therapist. She collaborates with her husband, Stephan Kerby, who runs the UnChurch, a DMT church in the Midwest. Together they navigate the evolving landscape of psychedelics, blending their expertise to support & collaborate in this transformative field.

jason burdge
Bohdi Norton HS

Jason Burdge & Bodhi Norton

Preliminary research study results on therapeutic harm reduction and psilocybin therapy in Oregon Psilocybin Services and unaffiliated professionals.

Presentation Abstract:  
Harm reduction has become a loosely defined term used in Oregon’s Psilocybin Services adult-supported use model and by other professionals assisting seekers in their mental health goals. Learn about the preliminary results of this comprehensive research study addressing perceptions and techniques.

Speaker Bio: Jason Burdge 
Jason has over 17 years of non-profit leadership experience with a Master’s degree in Nonprofit Administration. His focus has been on increasing mental health services to underserved communities. Jason is an advocate for educating and empowering others about the therapeutic use of psychedelics.

Speaker Bio: Bodhi Norton
Bodhi Norton (they/them) is a graduate student in the Sociology Ph.D. program at Portland State University, and is currently conducting research on Oregon Psilocybin Services, Oregon’s Measure 109, and therapeutic harm reduction. Bodhi double-majored in Criminal Justice Studies and Sociology and received their bachelor’s degree from Keene State College in 2021.

jason burdge
LR Headshot

Jason Burdge & Lisa Ritter

Assume nothing, Terms and phrases matter for positive therapeutic outcomes. Identifying the most common misconstrued terms in the psychedelic therapeutic space and strategies to achieve clarity.

Presentation Abstract:  
Join us for an engaging discussion on how language clarity can protect the community. More frequently we run into terms that can have different definitions or intentions depending on the speaker and listener. Explore how we can be more aware of terminology and common phrases associated with PAT.

Speaker Bio: Jason Burdge 
Jason has over 17 years of non-profit leadership experience and has a Master’s degree in Nonprofit Administration. His focus has been on increasing mental health services to underserved communities. Jason is an advocate for educating and empowering the community to promote mental health.

Speaker Bio: Lisa Ritter 
Lisa Ritter, LPC (she/her) Co-Founder and Chief Clinical Officer. Co-Founder & Chief Clinical Officer Lisa is a University of Oregon alum and licensed professional counselor with over twelve years of counseling experience. As a business owner of a private practice, Lisa is experienced in working with anxiety, depression, OCD, disordered eating, and trauma, and recognizes that psilocybin-assisted therapy is the next great opportunity for healing. Lisa implements her own integrative counseling approach, recognizing the importance of all domains of life (mental, emotional, physical, social, and spiritual) to one’s personal well-being and evolution.

6687002c8ff02

Danny Motyka

Psychedelic Spirituality: The Intersection of Science and Religion

Presentation Abstract:  

This presentation will explore whether the path of FDA approval for psychedelic assisted therapies is most appropriate, and will consider alternative means of access to improve spiritual wellness.

Speaker Bio: 

Danny Motyka is the CEO of Psygen Industries Ltd.

668a03a3a5596